CUB Domain Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration Resistant Prostate Cancer including PSMA Null Disease

Researchers evaluated if the cell surface protein CDCP1 could be exploited to treat metastatic CRPC with radioligand therapy, including in PSMA low subsets.